Riken Vitamin Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/07/01Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥55 | -49.3% |
| 2025 | ¥109 | +19.2% |
| 2024 | ¥91 | +36.8% |
| 2023 | ¥67 | +38.5% |
| 2022 | ¥48 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥88,750M | ¥91,484M | ¥95,582M | ¥96,300M |
| Gross Profit | ¥27,244M | ¥29,886M | ¥31,270M | ¥29,767M |
| Operating Income | ¥7,159M | ¥9,372M | ¥8,725M | ¥6,901M |
| Pretax Income | ¥7,989M | ¥12,021M | ¥12,829M | ¥10,358M |
| Net Income | ¥6,414M | ¥8,755M | ¥9,388M | ¥7,035M |
| EPS | ¥195.51 | ¥268.44 | ¥310.08 | ¥238.19 |
| Operating Margin | 8.07% | 10.24% | 9.13% | 7.17% |
| Balance Sheet | ||||
| Total Assets | ¥105,223M | ¥118,776M | ¥112,999M | ¥116,387M |
| Total Equity | ¥71,344M | ¥76,612M | ¥79,161M | ¥83,339M |
| Total Liabilities | ¥33,879M | ¥42,164M | ¥33,838M | ¥33,048M |
| Cash | ¥19,155M | ¥23,384M | ¥22,298M | ¥20,070M |
| Interest-bearing Debt | ¥14,560M | ¥16,053M | ¥9,914M | ¥7,141M |
| Equity Ratio | 67.80% | 64.50% | 70.05% | 71.61% |
| D/E Ratio | 0.20 | 0.21 | 0.13 | 0.09 |
| Cash Flow | ||||
| Operating CF | ¥7,835M | ¥10,451M | ¥7,892M | ¥5,963M |
| Investing CF | -¥2,034M | -¥554M | ¥353M | ¥1,747M |
| Financing CF | -¥4,578M | -¥7,084M | -¥9,965M | -¥8,040M |
| Free CF | ¥5,668M | ¥7,424M | ¥2,989M | ¥792M |
| Efficiency | ||||
| ROE | 8.99% | 11.43% | 11.86% | 8.44% |
| ROA | 6.10% | 7.37% | 8.31% | 6.04% |
Latest IR Information
-
Notice Regarding Share Buyback Status
Share buyback conducted. Target is common shares, planned cap at 900,000 shares, total amount up to 2,000,000,000 yen (cap). Actual buyback executed from July 1 to July 31, 2026, via market purchase: 192,500 shares, total 606,175,989 yen. Cumulative as of...
Read more -
Notice Regarding Share Buyback Status
Disclosure of share buyback status based on the board meeting resolution held on May 13, 2026. The target shares are common shares, with total shares acquired 165,800, total value 487,094,998 yen, acquisition period from June 1, 2026 to June 30,...
Read more -
Riken Vitamin Dividend Increase｜May 2026
Riken Vitamin has decided to pay a dividend of 55 yen for the fiscal year ending March 2026, with a total amount of 1,615 million yen. The dividend will take effect on June 8, 2026, representing an increase compared to...
Read more -
Notice of Change in President and Directors
Riken Vitamin Co., Ltd. has decided that Mr. Takahisa Nakano will resign as Executive President as of June 23, 2026, and Mr. Takumi Aoki will be newly appointed as a Director.
Read more -
Notice Regarding the Status and Completion of Treasury Stock Acquisition (Based on the Articles of Incorporation pursuant to Article 165, Paragraph 2 of the Companies Act)
Between March 1 and March 23, 2026, 53,300 shares of treasury stock were acquired for a total of 156,067,693 yen, bringing the cumulative acquisition total to 696,500 shares with a total acquisition cost of 1,999,887,013 yen, and the acquisition has...
Read more
Latest News (5 items)
Company Information
About
Riken Vitamin Co., Ltd. engages in the food ingredient, food and chemical improving agents, health care, consumer and commercial products, and vitamins businesses in Japan. It offers dressing, such as non-oil dressings; seaweed; and extract, seasoning, soup, soup stock, retort-packed food, salad-related products, seafood, meat extracts, and cut wakame. The company also provides food improving agents, including food emulsifiers, processed oils, natural colorants, and vitamin E, emulsification, anti staling, foaming, coagulation, anti-sticking, texture improvement, coloring, nutritional enhancement, and antioxidant to food manufacturers; and chemical improving agents for anti-fogging, plasticization, lubrication, anti-static, thickening, cleaning, mold release, dispersion, and antioxidant. In addition, it offers health care products comprising crocetin, a natural yellow colorant; mekabu fucoidan, a viscous ingredient; carotenoids; vitamin; and improving agents, such as pork extract. The company was formerly known as Riken Vitamin Oil Co., Ltd. and changed its name to Riken Vitamin Co., Ltd. in 1980. Riken Vitamin Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan.
